v3.23.2
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($)
$ in Thousands
6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
OPERATING ACTIVITIES    
Net loss $ (9,692) $ (9,433)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization 7,928 6,292
Stock-based compensation 5,415 3,296
Fair value adjustment of contingent consideration (2,974) (2,440)
Accretion of acquisition installment payable 812 1,545
Deferred income taxes (975) (756)
Changes in certain operating assets and liabilities:    
Accounts receivable - trade (8,964) (6,614)
Inventories (11,860) (10,905)
Prepaid expenses and other current assets 72 557
Accounts payable - trade 9,724 5,298
Accrued expenses and other liabilities 1,325 1,133
Other (1,645) (340)
Net cash used in operating activities (10,834) (12,367)
INVESTING ACTIVITIES    
Sale of short-term marketable securities 72,347 31,600
Payments to Acquire Marketable Securities (44,600) 0
Purchases of property and equipment (10,563) (9,465)
Net cash provided by investing activities 14,087 13,775
FINANCING ACTIVITIES    
Proceeds from issuance of debt with affiliate 0 31,000
Installment payment for ApiFix (2,000) (3,234)
Proceeds from exercise of stock options 0 42
Payments on mortgage notes (71) (67)
Net cash (used in) provided by financing activities (2,071) 27,741
Effect of exchange rate changes on cash, cash equivalents and restricted cash (335) 400
NET INCREASE IN CASH, CASH EQUIVALENTS AND RESTRICTED CASH 847 29,549
Cash, cash equivalents and restricted cash, beginning of year 10,462 9,006
Cash, cash equivalents and restricted cash, end of period 11,309 38,555
SUPPLEMENTAL DISCLOSURES    
Cash paid for interest 11 60
Transfer of instruments between property and equipment and inventory 367 (130)
Right-of-use assets obtained in exchange for lease liabilities 293 116
MD Ortho    
INVESTING ACTIVITIES    
Business acquisitions 0 (8,360)
SUPPLEMENTAL DISCLOSURES    
Issuance of common shares in acquisition 0 9,707
Medtech    
INVESTING ACTIVITIES    
Business acquisitions (3,097) 0
SUPPLEMENTAL DISCLOSURES    
Issuance of common shares in acquisition 2,274 0
ApiFix Ltd    
SUPPLEMENTAL DISCLOSURES    
Issuance of common shares in acquisition $ 6,178 $ 10,410